Related Experiment Video

Updated: Mar 9, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1

Shi Ying, Huang Jianjun, Yi Xue

    Oncology Research
    |January 7, 2017
    PubMed

    Insights

    MicroRNA-133b (miR-133b) is decreased in osteosarcoma, promoting tumor growth by targeting Sirt1. Restoring miR-133b may offer a new therapeutic strategy for osteosarcoma patients.

    Area of Science:

    • Molecular Biology
    • Oncology
    • Biochemistry

    Background:

    • MicroRNAs regulate gene expression by targeting messenger RNAs.
    • Osteosarcoma is a primary bone malignancy with significant metastatic potential.

    Purpose of the Study:

    • To investigate the role of miR-133b in osteosarcoma.
    • To identify the direct target of miR-133b and elucidate its mechanism of action in osteosarcoma progression.

    Main Methods:

    • Quantitative real-time PCR to measure miR-133b and Sirt1 expression.
    • Bioinformatic analysis and luciferase reporter assays to confirm Sirt1 as a direct target of miR-133b.
    • Cell proliferation and invasion assays to assess the functional impact of miR-133b and Sirt1.

    Main Results:

    • miR-133b expression was significantly downregulated in osteosarcoma tissues and cell lines.
    • Low miR-133b expression correlated with larger tumor size, metastasis, and advanced stage, predicting poor prognosis.
    • Sirt1 was identified as a direct target of miR-133b; miR-133b overexpression suppressed Sirt1, inhibiting osteosarcoma cell proliferation and invasion.
    • The miR-133b/Sirt1 axis influenced osteosarcoma progression via the Wnt/β-catenin pathway.

    Conclusions:

    • miR-133b acts as a tumor suppressor in osteosarcoma by targeting Sirt1.
    • The miR-133b/Sirt1 axis regulates osteosarcoma cell growth and invasion, potentially through the Wnt/β-catenin pathway.
    • miR-133b represents a promising therapeutic target for osteosarcoma treatment.

    More Related Videos

    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

    Published on: August 23, 2019

    7.8K
    An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

    An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

    Published on: May 21, 2019

    9.0K

    Related Concept Videos

    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    4.2K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
    24.5K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.0K
    Experimental RNAi02:15

    Experimental RNAi

    RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
    8.1K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.3K